Education
About Us
Working with TipRanks
Follow Us
Genedx Holdings Corp. (WGS)
:WGS
WGS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.63 - $115.60
Previous CloseN/A
Volume338.68K
Average Volume (3M)782.72K
Market Cap
$2.38B
Enterprise Value$2.13B
Total Cash (Recent Filing)$108.13M
Total Debt (Recent Filing)$45.02M
Price to Earnings (P/E)38.8
Beta1.36
Next Earnings
Apr 30, 2025EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.99
Shares Outstanding28,068,274
10 Day Avg. Volume759,034
30 Day Avg. Volume782,721
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.59
Price to Cash Flow (P/CF)-230.10
P/FCF Ratio0.00
Enterprise Value/Market Cap0.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.95
Enterprise Value/Ebitda-70.81
Forecast
1Y Price Target
$113.00Price Target Upside31.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
---
GeneDx Holdings News
PremiumCompany Announcements
GeneDx Reports Strong 2024 Growth and 2025 Outlook---
Bulls Say, Bears Say
Bulls Say
EarningsWGS generated a strong fourth-quarter performance with revenue of $95M, which is a 64% year-over-year increase and a 24% quarter-over-quarter increase, beating expectations.
Market PositionGeneDx is regarded as the dominant market leader in rare disease and whole exome testing, and the company is well positioned to increase its market penetration for many years to come.
Product InnovationThe introduction of ultraRapid Whole Genome Sequencing offers a competitive advantage and could increase adoption in the NICU market.
Bears Say
AllegationsA short report alleges wholesale reimbursement fraud at GeneDx, which led to a decrease in the company's shares.
Market ReactionShares of WGS are up ~40% after a strong Q4, as revenue beat by 16%, and WGS initiated a FY revenue guide which came in $16M above the Street at the midpoint, indicating the stock may be experiencing a period of volatility.
---
Ownership Overview
61.77% Insiders
4.65% Mutual Funds
1.03% Other Institutional Investors
26.40% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
WGS FAQ
What was Genedx Holdings Corp.’s price range in the past 12 months?
Genedx Holdings Corp. lowest stock price was $8.63 and its highest was $115.60 in the past 12 months.
What is Genedx Holdings Corp.’s market cap?
Genedx Holdings Corp.’s market cap is $2.38B.
When is Genedx Holdings Corp.’s upcoming earnings report date?
Genedx Holdings Corp.’s upcoming earnings report date is Apr 30, 2025 which is in 20 days.
How were Genedx Holdings Corp.’s earnings last quarter?
Genedx Holdings Corp. released its earnings results on Feb 18, 2025. The company reported $0.771 earnings per share for the quarter, beating the consensus estimate of $0.163 by $0.608.
Is Genedx Holdings Corp. overvalued?
According to Wall Street analysts Genedx Holdings Corp.’s price is currently Undervalued.
Does Genedx Holdings Corp. pay dividends?
Genedx Holdings Corp. does not currently pay dividends.
What is Genedx Holdings Corp.’s EPS estimate?
Genedx Holdings Corp.’s EPS estimate is 0.08.
How many shares outstanding does Genedx Holdings Corp. have?
Genedx Holdings Corp. has 28,068,274 shares outstanding.
What happened to Genedx Holdings Corp.’s price movement after its last earnings report?
Genedx Holdings Corp. reported an EPS of $0.771 in its last earnings report, beating expectations of $0.163. Following the earnings report the stock price went up 47.688%.
Which hedge fund is a major shareholder of Genedx Holdings Corp.?
Currently, no hedge funds are holding shares in WGS
---
GeneDx Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$113.00 (31.46% Upside)
$113.00 (31.46% Upside)
Blogger Sentiment
Bullish
WGS Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 444.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
723.37%
12-Months-Change
Fundamentals
Return on Equity
-22.10%
Trailing 12-Months
Asset Growth
-1.89%
Trailing 12-Months
Company Description
Genedx Holdings Corp.
GeneDx Holdings (WGS) is a company operating in the biotechnology sector, specializing in genomic diagnostics and precision medicine. The company focuses on providing genomic testing services that aid in the diagnosis and treatment of genetic disorders. GeneDx Holdings leverages advanced sequencing technologies and bioinformatics to offer a comprehensive range of genetic testing solutions, catering to healthcare providers, researchers, and patients. Its core services include exome and genome sequencing, as well as specific panels for hereditary conditions.
---
WGS Company Deck
---
WGS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
GeneDx reported strong financial performance with significant revenue and margin growth driven by the success of their exome and genome testing. They are making strategic investments to fuel future growth, including expanding their sales force and launching new products. However, challenges remain with high denial rates on test reimbursements and the decision to exit the hereditary cancer segment.Read More>---
WGS Revenue Breakdown
96.59% Diagnostic test revenue
3.41% Other
---
WGS Stock 12 Month Forecast
Average Price Target
$113.00
▲(31.46% Upside)
Technical Analysis
Best Analysts Covering WGS
1 Year
1 Year Success Rate
11/20 ratings generated profit
1 Year Average Return
+153.30%
reiterated a buy rating 25 days ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of +153.30% per trade.
---